Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
by computational/bioinformatics members of the team. Chimaera studies will be in partnership with our collaborator Ramiro Alberio at the University of Nottingham. About you Postdoctoral Research
-
, the role will involve the use of cutting-edge computational methods (structure/ligand-based design, AI/ML, virtual screening, chemo/bioinformatics, data-mining etc) to effectively advance programs with
-
Professor Nicholas Feasey on a range of projects related to infectious diseases and AMR. The successful candidates will have a PhD in bioinformatics, microbiology, virology, or a related field, ideally with
-
, neuroimaging, neurophysiology, proteomics, transcriptomics, epigenomics, metabolomics, bioinformatics, cell models and animal models. First in man and Phase 2, 3 and 4 clinical trials are also strongly supported
-
models with a key focus on integrating pathology, radiology, and electronic health records (EHRs), while collaborating with the bioinformatics team to incorporate molecular data such as bulk RNA-Seq, whole
-
, neuroimaging, neurophysiology, proteomics, transcriptomics, epigenomics, metabolomics, bioinformatics, cell models and animal models. First in man and Phase 2, 3 and 4 clinical trials are also strongly supported
-
models with a key focus on integrating pathology, radiology, and electronic health records (EHRs), while collaborating with the bioinformatics team to incorporate molecular data such as bulk RNA-Seq, whole
-
culture, cellular transfection, RNA expression analysis (qRT-PCR, RNA-seq), FACS analysis, Western blotting, ELISA, and bioinformatics. A background or interest in osteoarthritis, drug discovery, RNA
-
three-spined stickleback fish, using a mixture of field work, field and behavioural experiments, classical genetics and bioinformatics. The role holder will investigate the loss of male parental care in
-
, neuroimaging, neurophysiology, proteomics, transcriptomics, epigenomics, metabolomics, bioinformatics, cell models and animal models. First in man and Phase 2, 3 and 4 clinical trials are also strongly supported